
© Magnific
August 31, 2026
Prof. Dominik Pförringer
Medfluencers enjoy a high level of trust and reach millions with health advice. But on social media, reach often counts for more than scientific evidence. Prof. Dominik Pförringer examines the troubling intersection of medicine, influence, and commercial interests.

By
Univ.-Prof. Dr. med. Dominik Pförringer
The physician stands for reliable information and represents a rock amid the surf — a surf of half-truths, misguided marketing, and fake news.
Physicians ground their expertise and recommendations in a combination of acquired knowledge, an understanding of human nature, and ideally a wealth of experience. They examine, gather findings, data, and facts, weigh and reflect on them, and from this process arrive at diagnoses and explain treatment options.
These days, all it takes is a smartphone, a ring light, and a reasonably photogenic face to turn medical expertise into a media brand. The "medfluencer" is born — somewhere at the intersection of health education, personal branding, and advertising platform. Knowledge? Experience? Expertise? Scientific data? All of these may be partially present, but they are scrutinized far too rarely.
Medfluencers are not inherently a problem. Social media can convey basic medical knowledge in an accessible way, sometimes correct misinformation, and reach people that traditional health communication never does. The German Medical Association explicitly acknowledges that social media can be used effectively for health education and patient communication. The problem begins where education gives way to attention, and attention gives way to revenue.
Just how large this business has become is illustrated by the influencer marketing market. The German Association for the Digital Economy puts advertising spending in German influencer marketing for 2025 at around 718 million euros; a market volume of approximately 1.02 billion euros is projected for 2030.
A separately defined "medfluencer market" does not yet exist. This is hardly surprising from a methodological standpoint: the term is neither standardized nor protected. A recent review article estimates approximately 800 to 1,000 medfluencers in Germany — depending on the definition used.
These market figures should be treated with caution, but the underlying economic logic is fairly clear: anyone who combines perceived medical authority with a large audience has an exceptionally attractive proposition. The white lab coat is not merely a costume — it is a trust amplifier. And no one checks who is actually wearing it.
This not infrequently gives rise to a striking imbalance. A 2026 study published in JAMA Network Open analyzed 309 health-related YouTube videos by healthcare professionals on cancer and diabetes. The findings are striking: 62.5 percent of the medical claims examined were supported by very low or no evidence; only 19.7 percent were based on high-quality evidence.
Even more uncomfortable for the industry: videos with very low or absent evidence attracted more attention on average. After statistical adjustment, they were associated with approximately 35 percent higher view counts than videos backed by high-quality evidence.
This brings two fundamentally different systems into collision. Evidence-based medicine depends on the objective weighing of options, careful differentiation, critical appraisal of sources, and the willingness to say: "This cannot yet be conclusively proven." Social media, by contrast, rewards polarization, simplification, emotional appeal, and the clearest possible answers. "It depends on the individual situation and the current state of evidence" is medically accurate — but as a TikTok hook, it falls flat.
Things become particularly fraught when medical authority merges directly with commercial interest. Ärzte Zeitung reported in August 2026 on the case of a medfluencer who addressed an alleged "Pinocchio nose" on Instagram and promoted a corresponding medication.
The campaign behind it was part of an experiment, and the condition was entirely fabricated. The case is instructive not because it reflects poorly on any individual, but because of what it reveals about how the system operates: a professionally staged story, a plausible-sounding medical term, an ostensible expert voice — and just like that, a fiction had become a talking point.
One might be tempted to laugh, if the matter did not represent a serious problem in health communication. Because patients are rarely in a position to judge whether a claim is genuinely grounded in guidelines and randomized studies, or whether it rests solely on the influencer's personal experience — or even their imagination. Medical qualifications generate a trust premium that, on social media, can easily outstrip the actual evidence behind a claim.
It is also worth remembering that medical knowledge is not complete at the end of medical school; the state examination is merely the starting point of a long journey of accumulating knowledge and gathering experience. Extensive clinical and practical experience, a completed specialist qualification, and many grey hairs are the bare minimum — as has been made clear by political figures who brought none of that to the table.
The legislature attempts to place limits on this blending of information and advertising. The German Medicinal Products Advertising Act prohibits, outside professional circles, certain endorsements by healthcare professionals as well as misleading or insufficiently transparent advertising claims. The Act against Unfair Competition also covers misleading commercial practices and expressly addresses the use of paid editorial content when its advertising nature is not clearly identifiable.
The German Medical Association accordingly updated its guidance on the use of social media in 2023, explicitly incorporating the topic of "medical influencers." This was a sensible step, because medical confidentiality does not end at the smartphone, and a medical license is by no means a quality seal for an Instagram story.
None of this is meant to dismiss every medfluencer as a digital quack. Sound medical communication online can offer real societal benefit. A physician who explains complex subjects in plain language, puts studies in context, and is transparent about uncertainty is making a genuine contribution to public health education.
Yet one uncomfortable question must be asked: what happens when it is no longer the quality of medical information that determines what gets seen, but rather its marketability?
At that point, medical education quickly becomes content, content becomes a personal brand, and a personal brand becomes a business model. The outfit stays white. Only the line between patient information and sales promotion grows blurred.
Perhaps that is the true irony of the medfluencer age: medicine spent decades fighting to free itself from anecdotes, appeals to authority, and quackery — only to discover, of all places on Instagram, that a compelling face and a ring light are sometimes once again enough to sell old authority in a new light.
Dear reader: be wary of those who proclaim certainty the loudest — especially where science is still asking questions.

Medfluencers enjoy a high level of trust and reach millions with health advice. But on social media, reach often counts for more than scientific evidence. Prof. Dominik Pförringer examines the troubling intersection of medicine, influence, and commercial interests.
Prof. Dominik Pförringer

By
Univ.-Prof. Dr. med. Dominik Pförringer

Wegovy is now available as a pill. But how does it compare with the weekly injection? Prof. Uwe Nixdorff explains the key differences in effectiveness, use, and side effects.
Christine Bürg & Marianne Waldenfels

With
Prof. Dr. Uwe Nixdorff

When pregnancy doesn’t happen, the uncertainty can take a heavy toll on couples. Reproductive medicine specialist Dr. Bernd Lesoine explains why age matters, when to seek medical advice, and which treatments offer the best chances of success.
Christine Bürg & Marianne Waldenfels